Clinical Trial: Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866261) titled 'Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED' on Oct. 04.

Brief Summary: This randomized controlled trial aims to compare the efficacy and safety of transconjunctival versus transcutaneous perilevator betamethasone injection in reducing upper eyelid retraction in patients with thyroid eye disease.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Thyroid Eye Disease

Intervention: DRUG: Betamethasone

Betamethasone suspension 1 mL injected into the perilevator space.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible ...